Bullish indicating open at $55-$60, IPO prices at $37
PLYMOUTH MEETING, Pa. -On Tuesday, AdaptHealth Corp. (NASDAQ:AHCO) reported fourth quarter earnings that beat analyst expectations, while issuing revenue guidance for fiscal year 2025.
The healthcare equipment provider posted adjusted earnings per share of $0.34 for Q4, surpassing the analyst consensus estimate of $0.28. Revenue came in at $856.6 million, topping expectations of $829.19 million but down slightly from $858.2 million in the same quarter last year.
For the full year 2024, AdaptHealth generated net revenue of $3.26 billion, up 1.9% from $3.20 billion in 2023. Adjusted EBITDA increased 2.7% to $688.7 million.
Looking ahead, the company provided fiscal 2025 revenue guidance of $3.22 billion to $3.36 billion, compared to analyst estimates of $3.33 billion. AdaptHealth also expects adjusted EBITDA of $670 million to $710 million and free cash flow of $180 million to $220 million for 2025.
"Over the course of the second half of 2024, we continued to make progress on our five areas of focus, which include our One Adapt initiative, accelerating the application of AI and automation, increasing our clinical relevance, delivering organic growth, and strengthening our balance sheet," said CEO Suzanne Foster.
The company will host a conference call at 8:30 AM ET to discuss the results further.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.